Crispr Therapeutics Ag
CRSP
$44.25-0.18 (-0.41%)
Jun 22, 2025, 4:00 PM
Financials
| 52Week High | 63.68 | 52Week Low | 30.04 |
| Beta | 1.73 | Current Ratio Annual | 22.07 |
| Current Ratio Quarterly | 15.64 | Market Cap | 3.82B |
| Net Profit Margin TTM | -1,023.64 | Operating Margin TTM | -1,259.20 |
| Price To Book | 2.09 | Price To Free Cash Flow TTM | 35.05 |
| Price To Sales TTM | 101.44 | Quick Ratio Annual | 21.97 |
| Quick Ratio Quarterly | 15.53 | Return On Assets TTM | -17.13 |
| Return On Equity TTM | -20.08 | Return On Investment TTM | -20.08 |
| Revenue Growth3Y | -65.58 | Revenue Growth5Y | -33.62 |
| Revenue Growth Quarterly Yoy | 71.63 | Revenue Growth TTMYoy | -86.13 |
| Revenue Per Share TTM | 0.44 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 404 | 2 | 0 | 4 | 6 | 4 | 68.01M | $2.45B |
| Mar 31, 2025 | 370 | 48 | 68 | 118 | 101 | 99 | 67.95M | $2.12B |
| Change | 34(8%) | 46(2300%) | 68 | 114(2850%) | 95(1583%) | 95(2375%) | 59.87K(0%) | $330.29M(13%) |